Prostaglandin levels in cerebrospinal fluid from multiple sclerosis patients in remission and relapse.
Radioimmunoassay (RIA) techniques have been employed to determine prostaglandin (PG) levels in the cerebrospinal fluid (CSF) from multiple sclerosis (MS) patients in remission and relapse and in subjects with other neurological diseases (OND). PGE and PGF2 alpha concentrations in spinal fluid from MS patients in relapse were significantly lower than values estimated during remission and in individuals with OND of the central nervous system (CNS). These observations are discussed in relation to the clinical state of patients with demyelinating disease together with a consideration of the concept that disordered immune mechanisms contribute a central role in the pathogenesis of MS.
D015237:Dinoprost; D006801:Humans; D007958:Leukocyte Count; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000209:etiology / Q000276:immunology; D011453:Prostaglandins / Q000134:cerebrospinal fluid*; D011458:Prostaglandins E / Q000134:cerebrospinal fluid; D011460:Prostaglandins F / Q000134:cerebrospinal fluid; D012008:Recurrence
D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D015237:Dinoprost; C100006:prostaglandin F1